Carnosine for Peripheral Vascular Disease

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 104 participants.

Also called NCT03844113

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 104 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03844113
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Australia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03844113. Randomized; quadruple masking; primary purpose treatment. Start 2019-03-01 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Carnosine for Peripheral Vascular Disease
Acronym
Car-PVD
Condition
Peripheral Arterial Disease
Intervention (Drug)
Carnosine
Intervention (Drug)
Placebo
Lead sponsor
Monash University (class: other)
Collaborator
Monash Health (class: other)

Record details

Record id
cardio:ct-nct03844113
Content hash
353b4ac98ef2453f2e30fe0afce177a8fda1ee22aa2952f307152b5b4d25ecac